Doxee Spa has obtained a grant of US$4 million from the EC program Horizon 2020
October 2015 — Doxee Spa has raised US$4 million through a grant negotiated with the European Commission.
Doxee Spa was established in 2001as Ebilling Spa and has its headquarters in Modena, Italy. Secondary offices are located in California, USA, Rome, Italy, and Prague, Czech Republic. Doxee delivers cloud-based solutions and services for customer communication management (CCM), document process outsourcing and paperless transition for business enterprises and service providers worldwide. Doxee provides its services to more than 500 clients worldwide, covering different business sectors such as banking and finances, telecom and media, public utilities, and insurance healthcare. In addition, Doxee develops a self-administered personalized activity system, the iPAS, for the consumer market, for risk-screening, assessment and personalized behavioural change interventions for ageing people at risk of functional decline. The company has 77 employees. A recent research by the Gartner Group has classified Doxee among the top 15 players for CCM software at global level.
Our role in the transaction
Oaklins' team in Italy advised Doxee Spa on the fundraising process providing strategic evaluation, financial assessment, selection of the right financial instrument, project information memorandum preparation and submission to the European Commission, and financial structuring and negotiation.
Talk to the deal team
Related deals
Katalyst Diagnostics has been acquired by Cruinn Diagnostics
Katalyst Diagnostics Ltd. has been acquired by Cruinn Diagnostics Ltd. The acquisition strengthens Cruinn Diagnostics’ presence in the UK diagnostics market, adding established NHS customer relationships, local commercial infrastructure and a complementary portfolio of point-of-care diagnostic solutions. It also creates opportunities to introduce Cruinn Diagnostics’ products to UK customers while leveraging its established Irish platform to accelerate the growth of Katalyst Diagnostics’ portfolio in Ireland. With more than 100 employees and revenues in excess of US$56 million, the combined business will continue to focus on the UK market, where Cruinn Diagnostics sees significant opportunities to expand through further investment and targeted M&A.
Learn moreNextalia has acquired a majority stake in Witapp
Nextalia SGR S.p.A. has acquired a majority stake in Witapp S.r.l., an Italian company specializing in software development for the digitization of healthcare infrastructure. The acquisition strengthens Nextalia’s track record in technology companies serving the public sector and supports its strategy of investing in businesses operating at the intersection of healthcare digitization and the modernization of public services.
Learn moreLife & Mobility has attracted investor Bolster Investment Partners
Life & Mobility, a leading developer and manufacturer of premium mobility and rehabilitation solutions, has welcomed Bolster Investment Partners as a new shareholder. The partnership provides Life & Mobility with a strong long-term partner to support the company’s next phase of growth, with a continued focus on product innovation, strengthening its leading market position and further international expansion. The company’s mission remains to enhance the mobility, independence and quality of life of end users through innovative, sustainable and circular mobility solutions designed for multiple life cycles.
Learn more